Cookies

Like most websites The Ophthalmologist uses cookies. In order to deliver a personalized, responsive service and to improve the site, we remember and store information about how you use it. Learn more.
Subspecialties Cornea / Ocular Surface, Business and Innovation, Health Economics and Policy, Imaging & Diagnostics

CXL Unbound

Sometimes, the sheer scale of an unmet need can surprise you. For many years, keratoconus was thought of as a rare disease: in 1986, a paper reported that 1 in 2000 people in Olmstead County, Minnesota, had keratoconus. And that figure stuck for at least 30 years. But modern diagnostics revealed a different story. Keratoconus rates are higher – and vary by continent and climate. And that’s why efforts like the K-MAP global keratoconus prevalence study are so important; accurate data reveals the true unmet need.

We know that CXL renders the cornea sterile – so why perform the procedure in the OR?

Read the full article now

Log in or register to read this article in full and gain access to The Ophthalmologist’s entire content archive. It’s FREE and always will be!

Login

Or register now - it’s free and always will be!

You will benefit from:

  • Unlimited access to ALL articles
  • News, interviews & opinions from leading industry experts
  • Receive print (and PDF) copies of The Ophthalmologist magazine
Register

Or Login via Social Media

By clicking on any of the above social media links, you are agreeing to our Privacy Notice.

About the Author

Farhad Hafezi

Farhad Hafezi

As a post-doc, Farhad Hafezi identified a gene that can completely inhibit light induced retinal damage in mice. Instrumental in building IROC in Zurich, today his clinical focus is on corneal and refractive laser surgery and enhancing and extending the use of corneal collagen cross-linking (CXL); Farhad was a 2014 Carl Camras award recipient for this work

Register to The Ophthalmologist

Register to access our FREE online portfolio, request the magazine in print and manage your preferences.

You will benefit from:

  • Unlimited access to ALL articles
  • News, interviews & opinions from leading industry experts
  • Receive print (and PDF) copies of The Ophthalmologist magazine

Register